Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up

Clinical and Experimental Immunology

Volumn 110, Issue 1, 1997, Pages 4-8

  Christie, J M L ^a   Healey, C J ^a   Watson, J ^a   Wong, V S ^a   Duddridge, M ^a   Snowden, N ^a   Rosenberg, W M C ^a   Fleming, K A ^a   Chapel, H ^a   Chapman, R W G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Hepatitis c virus; Immunoglobulins; Immunologic deficiency syndromes; Interferons

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG CONTAMINATION; DRUG MEGADOSE; EPIDEMIC; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPOGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LIVER FAILURE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED KINGDOM; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 9844267962     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.508-ce1412.x     Document Type: Article

References (19)

1. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. MMWR 1994; 43:505-9.
2. Yu MW, Mason BL, Guo ZP, Tankersley DL, Nedjar S, Mitchell FD, Biswas RM. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 1995; 345:1173-4.
3. Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, Chapman RWG, Simmonds P, Chapel H. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus screened intravenous immunoglobulin therapy. Gastroenterology 1996; 110:1120-6.
4. Webster ADB, Lever AML. Non-A non-B hepatitis after intravenous gammaglobulin [letter]. Lancet 1986; 327:332.
5. Weiland O, Mattsson L, Glaumann H. Non-A, non-B hepatitis after intravenous gammaglobulin [letter]. Lancet 1986; 327:976-7.
6. Thomson BJ, Doran M, Lever AM, Webster AD. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet 1987; 329:539-41.
7. Bjorkander J, Cunningham RC, Lundin P, Olsson R, Soderstrom R, Hanson LA. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988; 84:107-11.
8. Bjoro MD, Froland SS, Yun Z, Samdal HH, Haaland MD. Hepatitis C infection in patients with primary hypogammaglobulinaemia after treatment with contaminated immune globulin. N Engl Med 1994; 331:1607-11.
9. Alberti A, Chemello L, Bonetti P, Casarin C, Diodati G, Cavalletto D, Frezza M, Donada C, Belussi F, Casarin P, Pozzato et al. Treatment with interferons of community-acquired chronic hepatitis and cirrhosis type C. J Hepatol 1993;17(Suppl.3):S123-6.
10. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 1994; 21:1-3.
11. Viladomiu L, Genesca J, Estaban JI, Allende H, Gonzalez A, Lopez-Talavera JC, Esteban R, Guardia J. Interferon-α in acute posttransfusion hepatitis C: a randomised controlled trial. Hepatology 1992; 15:767-9.
12. Lampertico P, Rumi M, Romeo R, Craxi A, Soffredini R, Biassoni D, Colombo M. A multicenter randomized controlled trial of recombinant interferon-alpha in patients with acute transfusion-associated hepatitis C. Hepatology 1994; 19:19-22.
13. Chapel HM. Consensus in diagnosis and management of primary antibody deficiencies. Br Med J 1994; 308:581.
14. Seef LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter, HJ, Iber FL, et al. Long term mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992; 327:1906-11.
15. Smith MSH, Webster DB, Dhillon AP, Dusheiko G, Boulton R, Savage K, Rolles K, Burroughs AK. Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. Gastroenterology 1995; 108:879-84.
16. Leen CLS, Bath JCJL, Brettle RP, Yap PL. Sarcoidosis and primary hypogammaglobulinaemia: a report of two cases and a review of the literature. Sarcoidosis 1985; 2:91-5.
17. Dusheiko G, Schmilovitz H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19:13-18.
18. Simons JN, Leary TP, Dawson GJ, Pitol-Matias TJ, Muerhoff AS Schlauder GG, Desai SM, Mushahwar IK. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1:564-8.
19. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-9.